Research Highlights from ACTRIMS Forum 2023
On February 23-25, 2023, the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum took place in San Diego,…
On February 23-25, 2023, the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum took place in San Diego,…
Looking back at this past year in research, we reflect on key advances that are accelerating our understanding of multiple sclerosis (MS) and…
On October 26-28, 2022, the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) gathered scientists, clinicians, and…
On October 13-15, the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) organized a fully digital experience…
Through the generous support of the MS community, event participants, and donors, the Multiple Sclerosis Society of Canada has invested over $204 million…
This blog post was published in October 2021 for #WorldMentalHealthDay to raise awareness of mental health as an integral part of overall health.…
Drs. Michelle Ploughman (Memorial University of Newfoundland) and Sarah Donkers (University of Saskatchewan) are set to lead the first Canadian clinical trial examining…
Kelsi Smith is a Canadian who is pursuing her PhD in the area of neuroscience and epidemiology at Karolinska Insitutet. In 2020, Kelsi…
Guest post by MS Walk ambassador, Darcie opens up about how her neurologist’s foresight saved her quality of life. I like to think that I’m…
Women in Canada are three times more likely to develop MS than men. Women also face significant barriers to finding reliable information about…